Evolv Technologies (EVLV): Customer Footprint and What It Means for Revenue Predictability
Evolv sells AI-driven, contactless weapons-detection systems and monetizes primarily through multi-year subscription and leasing arrangements that combine hardware, software and services; the company also recognizes product sales and licensing revenue. The result is a recurring-revenue business concentrated in high-visibility verticals — stadiums, college athletics, hospitals and select enterprise channels — where long-term contracts and renewals drive predictable cash flows.
Discover more about relationship signals and coverage at https://nullexposure.com/.
A customer roll call with context — who’s buying Evolv and why it matters
Below I list every customer relationship surfaced in the filings and press coverage available, with a concise plain-English summary and the original source.
Columbia Tech
Evolv discloses Columbia Tech in its FY2024 10‑K in the context of accounts receivable and customer concentration risk, indicating a material commercial relationship through distribution or resale. According to the FY2024 10‑K, Columbia Tech is referenced in customer concentration and accounts receivable disclosures.
Motorola Solutions Inc.
Motorola Solutions is cited in the FY2024 10‑K under sales revenue and customer concentration language, implying a meaningful revenue relationship or channel arrangement with Evolv during the referenced period. This is noted in Evolv’s FY2024 10‑K filings.
Bank of America Stadium
Bank of America Stadium has completed a long‑term renewal and upgraded to the Gen2 Evolv Express platform, reflecting a hardware-and-subscription renewal with Evolv ahead of the 2026 season. That detail comes from Evolv’s 2025 Q3 earnings call and subsequent press coverage in March 2026.
Buffalo Sabres
The Buffalo Sabres committed to a multiyear subscription for nine Evolv Express Gen2 systems at KeyBank Center, representing a venue-level subscription win in professional hockey. Evolv executives described this agreement on the 2025 Q3 earnings call and it was highlighted in industry coverage in early 2026.
Seattle Children’s Hospital
Seattle Children’s Hospital is listed among recent healthcare wins, showing Evolv’s penetration into the hospital vertical where security and throughput are priorities. This was referenced during the company’s 2025 Q3 earnings commentary.
UC Davis Health
UC Davis Health was named alongside other healthcare customers as a recent win, indicating expansion of Evolv’s installed base in large health systems. The mention appears in Evolv’s 2025 Q3 earnings call comments.
University of North Carolina at Chapel Hill
UNC Chapel Hill is integrating Evolv Express at its athletic venues to streamline entry and enhance safety, a collegiate athletics deployment cited during the 2025 Q3 earnings call.
WellSpan Health
WellSpan Health was announced as a recent healthcare customer, reinforcing the company’s growth into enterprise health systems; this was disclosed on the 2025 Q3 earnings call.
American Hospital Association
Evolv was selected as the American Hospital Association’s preferred physical security provider, a channel/endorsement that materially increases visibility into the healthcare market and was publicized via BusinessWire/MarketBeat in February 2026.
FC Cincinnati / TQL Stadium
FC Cincinnati added Evolv Express systems at TQL Stadium entrances, a stadium-level deployment indicating continued adoption across Major League Soccer venues; this was reported in February–March 2026 industry press and Evolv press releases.
Miami Freedom Park
Miami Freedom Park selected Evolv for guest ingress screening at the new stadium project, a strategic stadium win announced in February 2026 coverage and company releases.
Pechanga Arena (Pechanga Arena San Diego)
Evolv deployed Evolv Express at Pechanga Arena in San Diego, expanding the company’s Southern California footprint in live entertainment venues; the deployment was reported in December 2025/early 2026 press.
Shell Energy Stadium
Shell Energy Stadium enhanced its live-event screening with Evolv technology, another stadium deployment publicized in February 2026 press coverage.
Carolina Athletics
Carolina Athletics (reflecting college sports customers in North Carolina) expanded its use of Evolv systems, a relationship called out in February 2026 company press and media summaries.
(References: Evolv FY2024 10‑K disclosures; Evolv 2025 Q3 earnings call; press coverage compiled in March 2026 via Finviz/MarketBeat/Marketscreener/SimpleWall summaries and Evolv press releases.)
What these customer relationships collectively tell investors
- Subscription-first commercial model. Evolv’s contracts are predominantly multi‑year, subscription or lease agreements that bundle hardware, SaaS and maintenance; the 10‑K explains most agreements include non‑cancelable initial terms typically around four years, which underpins revenue visibility.
- Venue-driven concentration but broadening coverage. The customer list shows a strategic focus on sports & live entertainment and healthcare, with stadium renewals and hospital endorsements driving both unit sales and recurring fees. This sector focus creates sticky relationships but concentrates commercial risk by vertical.
- U.S. centricity with global reach signals. Revenue is primarily U.S. based, though the company reports global installations and over two billion screened visitors worldwide — indicating product-market fit outside the U.S. but concentrated financial exposure domestically.
- Hybrid seller role and channel complexity. Evolv acts as a direct seller and partner via resellers/distributors (e.g., referenced distribution agreements), while also providing professional services (installation, training, event support), which increases go‑to‑market flexibility but adds operational complexity.
These are company-level signals drawn from Evolv’s public filings and investor disclosures (10‑K and management commentary).
Explore deeper relationship analytics at https://nullexposure.com/.
Investment implications and risk checklist
- Predictable revenue profile: Multi‑year subscriptions increase revenue visibility and drive higher lifetime value, supporting valuation multiples that assume subscription growth. Evolv’s FY‑TTM revenue and gross-profit levels show the business is scaling but not yet profitable on net income per the latest filings.
- Renewal and expansion are critical: Stadium renewals (Bank of America Stadium, TQL Stadium, others) and multi‑year deals (Buffalo Sabres) are key earnings drivers; missed renewals would materially affect near-term revenue.
- Vertical concentration risk: Heavy reliance on sports, entertainment and hospitals concentrates demand shocks (event cancellations, budget cuts) but also offers concentrated upsell opportunities for site expansions and ancillary services.
- Channel and distributor exposure: Relationships with resellers (e.g., Columbia Tech referenced in the 10‑K) diversify reach but create margin and control tradeoffs; management retains inventory and pricing discretion in reseller deals per the 10‑K.
Bottom line and next steps for due diligence
Evolv’s subscription-driven model and growing roster of stadium and hospital clients create a foundation for recurring revenue, but investors must monitor renewal economics, geographic diversification, and gross‑to‑net conversion as hardware sales and services mix shift. For a focused view of customer relationships and enterprise exposures, review Evolv’s filings and the summarized relationship signals at https://nullexposure.com/.
If you want a tailored brief on Evolv’s contract maturity curve or venue-level revenue sensitivity, start here: https://nullexposure.com/.